Zafran
2 Case Studies
Case Study: a Fortune 500 pharmaceutical company cuts critical vulnerabilities by 95% with Zafran
A Zafran Case Study
How a Global Pharma Leader Transformed Security Using Risk-Based Vulnerability Prioritization
A Fortune 500 pharmaceutical company operating globally faced significant challenges in managing over 300,000 assets and prioritizing vulnerabilities. Their security teams were overwhelmed, as their tools could not identify which vulnerabilities were truly exploitable, often lacking context from internet exposure or existing compensating controls. Zafran was engaged to address this.
Zafran implemented its risk-based vulnerability prioritization platform to aggregate data and apply advanced risk context. This enabled the customer to identify the tiny fraction of internet-facing, critical assets that were actually exploitable and to leverage their existing defenses for mitigation. The solution delivered a 95% reduction in critical vulnerabilities, allowing security teams to focus their efforts effectively and achieve immediate risk reduction.
View this case study…